首页> 美国卫生研究院文献>PLoS Clinical Trials >Histone Demethylase Jumonji D3 (JMJD3) as a Tumor Suppressor by Regulating p53 Protein Nuclear Stabilization
【2h】

Histone Demethylase Jumonji D3 (JMJD3) as a Tumor Suppressor by Regulating p53 Protein Nuclear Stabilization

机译:组蛋白脱甲基酶Jumonji D3(JMJD3)通过调节p53蛋白核稳定作用作为肿瘤抑制因子。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Histone methylation regulates normal stem cell fate decisions through a coordinated interplay between histone methyltransferases and demethylases at lineage specific genes. Malignant transformation is associated with aberrant accumulation of repressive histone modifications, such as polycomb mediated histone 3 lysine 27 (H3K27me3) resulting in a histone methylation mediated block to differentiation. The relevance, however, of histone demethylases in cancer remains less clear. We report that JMJD3, a H3K27me3 demethylase, is induced during differentiation of glioblastoma stem cells (GSCs), where it promotes a differentiation-like phenotype via chromatin dependent (INK4A/ARF locus activation) and chromatin independent (nuclear p53 protein stabilization) mechanisms. Our findings indicate that deregulation of JMJD3 may contribute to gliomagenesis via inhibition of the p53 pathway resulting in a block to terminal differentiation.
机译:组蛋白甲基化通过沿袭特定基因的组蛋白甲基转移酶和脱甲基酶之间的协调相互作用来调节正常的干细胞命运决定。恶性转化与抑制性组蛋白修饰的异常积累有关,例如聚梳介导的组蛋白3赖氨酸27(H3K27me3)导致组蛋白甲基化介导的分化阻滞。 。但是,组蛋白脱甲基酶与癌症的相关性仍然不清楚。我们报告说,JMJD3,H3K27me3脱甲基酶,是在胶质母细胞瘤干细胞(GSCs)分化过程中诱导的,它通过染色质依赖性(INK4A / ARF基因座激活)和染色质非依赖性(核p53蛋白稳定)机制促进分化样表型。我们的发现表明,JMJD3的失调可能通过抑制p53途径而导致神经胶质瘤的发生,从而阻止了终末分化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号